Results 61 to 70 of about 350,390 (302)

A brief overview of current drug repurposing approaches for COVID-19 management [PDF]

open access: yes, 2020
This brief overview is intended to shed light on the current drug repositioning (also called drug repurposing) in the therapeutics of the novel coronavirus disease which emerged in 2019 (COVID-19).
Rodrigues, Pedro da Fonseca Soares   +1 more
core   +2 more sources

ANTIVIRAL DRUGS IN THE TREATMENT FOR COVID-19

open access: yesАктуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії, 2023
Introduction. Covid-19 is an infectious contagious disease of viral etiology caused by SARS-COv-2. Covid-19 is a highly infectious viral disease caused by SARS-CoV-2. The management of Covid-19 presents significant challenges, and the decision regarding the level of medical care provided, whether in outpatient or hospital settings, relies ...
openaire   +1 more source

An Overview of Repurposed Drugs for Potential COVID-19 Treatment

open access: yesAntibiotics, 2022
The COVID-19 pandemic caused by SARS-CoV-2 has placed severe constraints on healthcare systems around the globe. The SARS-CoV-2 virus has caused upheaval in the healthcare and economic sectors worldwide. On the 20th of May 2020, the World Health Organisation declared COVID-19 a global pandemic due to the unprecedented number of cases reported around ...
Kamini Govender, Anil Chuturgoon
openaire   +3 more sources

Antibiotics in acute bronchitis: a meta-analysis. [PDF]

open access: yes, 1999
PurposeMost patients with acute bronchitis who seek medical care are treated with antibiotics, although the effectiveness of this intervention is uncertain.
Bent, S   +3 more
core   +1 more source

Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference

open access: yesiScience, 2022
Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen of coronavirus disease 2019 (COVID-19), has infected hundreds of millions of people and caused millions of deaths.
Jianhua Wang   +12 more
doaj   +1 more source

Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Atrial fibrillation is a common clinical manifestation in hospitalized patients with coronavirus disease 2019 (COVID‐19). Medications used to treat atrial fibrillation, such as antiarrhythmic drugs and anticoagulants, may have significant drug ...
Pattara Rattanawong   +6 more
doaj   +1 more source

Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature [PDF]

open access: yes, 2020
In March 2020, the World Health Organization declared the spread of SARS-CoV-2 a global pandemic. To date, coronavirus disease-2019 (COVID-19) has spread to over 200 countries, leading to over 1.6 million cases and over 99,000 deaths. Given that there is
Aly, Besma   +9 more
core  

Recommendations for the outpatient drug treatment of patients with COVID-19

open access: yesDeutsches Ärzteblatt international, 2022
One of the purposes of outpatient treatment for COVID-19 patients is to prevent severe disease courses and hospitalization. There is a need for evidence-based recommendations to be applied in primary care and specialized outpatient settings.This guideline was developed on the basis of publications that were retrieved by a systematic search for ...
Kaduszkiewicz, Hanna   +5 more
openaire   +4 more sources

Role of monoclonal antibody drugs in the treatment of COVID-19

open access: yesWorld Journal of Clinical Cases, 2020
Currently clinicians all around the world are experiencing a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical presentation of this pathology includes fever, dry cough, fatigue and acute respiratory distress syndrome that can lead to death infected patients.
Ucciferri C., Vecchiet J., Falasca K.
openaire   +3 more sources

Potential therapeutic drug candidates against SARS-CoV-2 (COVID‐19) through molecular docking: A review [PDF]

open access: yesHealth Science Monitor, 2022
The severe acute respiratory syndrome coronavirus 2 (known as COVID-19), initially appeared in the Wuhan city of China in December 2019, has become a current medical issue around the world.
Aynaz Nourani   +2 more
doaj  

Home - About - Disclaimer - Privacy